Mark Burkin Selected Research

Cholesterol

8/2013

Relationships between pharmacotherapy-induced metabolic changes and improved psychopathology in schizophrenia: data from a mirtazapine and first-generation antipsychotics combination trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Burkin Research Topics

Disease

8	Schizophrenia (Dementia Praecox) 01/2017 - 03/2009
1	Weight Gain 08/2013
1	Body Weight (Weight, Body) 08/2013
1	Psychotic Disorders (Schizoaffective Disorder) 04/2011

Drug/Important Bio-Agent (IBA)

8	Mirtazapine (Rexer)FDA LinkGeneric 01/2017 - 03/2009
7	Antipsychotic Agents (Antipsychotics)IBA 01/2017 - 03/2009
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2017
1	Antidepressive Agents (Antidepressants)IBA 01/2017
1	CholesterolIBA 08/2013
1	Clozapine (Clozaril)FDA LinkGeneric 03/2009

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 08/2013